ROBERT BALL

FDA - Deputy Director | Office of Surveillance and Epidemiology (OSE)

SESSION 12. REGULATORY ASPECTS FOR IMPLEMENTING ARTIFICIAL INTELLIGENCE IN PV

November, Thursday 20 | 13:45 - 15:20 , EUPV Congress Virtual Conference Hall

Regulatory aspect on AI in PV